Niagen Bioscience Sponsors Inaugural NAD+ Health Conference at University of Copenhagen — Niagen Bioscience, Inc.

Event summary

Niagen Bioscience is the headline sponsor of the inaugural 'NAD for Health: Opportunities & Challenges' conference, hosted by the University of Copenhagen, taking place March 23–25, 2026.
The conference focuses on NAD+ metabolism and its implications for human health, featuring thought leaders from world-renowned institutions.
Key scientific themes include NAD+ precursor strategies for rare diseases, interventions to improve healthspan, and translational frameworks for clinical trials.
The event includes thematic sessions, a panel discussion (livestreamed globally), and a poster session for early-career researchers.
Registration is required and subject to confirmation, with a deadline of February 15, 2026.

The big picture

Niagen Bioscience's sponsorship of this high-profile conference underscores its commitment to advancing NAD+ science through rigorous, evidence-based collaboration. The event aligns with broader industry trends toward precision science in healthy aging, positioning Niagen Bioscience as a key player in shaping the future of NAD+-boosting solutions. The focus on translational frameworks and clinical trials highlights the strategic importance of bridging basic research with practical health outcomes.

What we're watching

Scientific Collaboration: How the interdisciplinary dialogue at the conference will impact the standardization of NAD+ research and clinical translation.
Regulatory Considerations: Whether the conference's focus on trial design and biomarkers will accelerate regulatory approvals for NAD+-based therapies.
Market Positioning: The pace at which Niagen Bioscience can leverage this event to solidify its leadership in the NAD+ science and healthy-aging research space.